المؤلفون: Tomlinson B; Faculty of Medicine, Macau University of Science and Technology, Macau China., Patil NG; Faculty of Medicine, Macau University of Science and Technology, Macau China., Fok M; Faculty of Medicine, Macau University of Science and Technology, Macau China., Lam CWK; Faculty of Medicine, Macau University of Science and Technology, Macau China.

المصدر: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2021 Nov; Vol. 22 (16), pp. 2221-2234. Date of Electronic Publication: 2021 Jun 13.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents* , Cardiovascular Diseases* , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Dyslipidemias*/complications , Dyslipidemias*/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors* , Pancreatitis*, Acute Disease ; Humans ; Proprotein Convertase 9

المؤلفون: Tomlinson B; Faculty of Medicine, Macau University of Science & Technology, Macau 999078, PR China., Lin CH; Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan., Chan P; Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan., Lam CW; Faculty of Medicine, Macau University of Science & Technology, Macau 999078, PR China.

المصدر: Personalized medicine [Per Med] 2021 Mar; Vol. 18 (2), pp. 185-203. Date of Electronic Publication: 2021 Feb 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Future Medicine Country of Publication: England NLM ID: 101238549 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-828X (Electronic) Linking ISSN: 17410541 NLM ISO Abbreviation: Per Med Subsets: MEDLINE

مواضيع طبية MeSH: Dyslipidemias/*drug therapy , Dyslipidemias/*physiopathology , Hypolipidemic Agents/*pharmacology , Hypolipidemic Agents/*therapeutic use , Precision Medicine/*methods, Age Factors ; Body Mass Index ; Cholesterol, LDL/drug effects ; Comorbidity ; Dyslipidemias/genetics ; Fatty Acids, Omega-3/therapeutic use ; Fibric Acids/therapeutic use ; Genetic Predisposition to Disease ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypolipidemic Agents/adverse effects ; Lipoprotein(a)/drug effects ; Proprotein Convertase 9/drug effects ; RNA, Small Interfering ; Sex Factors ; Triglycerides/metabolism

المؤلفون: Rymer JA; Duke Clinical Research Institute Durham NC., Mues KE; Center for Observational Research Amgen Inc Thousand Oaks CA., Monda KL; Center for Observational Research Amgen Inc Thousand Oaks CA., Bratton EW; IQVIA, Real-World Evidence Solutions Durham NC., Wirtz HS; Center for Observational Research Amgen Inc Thousand Oaks CA., Okerson T; Center for Observational Research Amgen Inc Thousand Oaks CA., Overman RA; NoviSci, Inc Durham NC., Brookhart MA; NoviSci, Inc Durham NC.; University of North Carolina at Chapel Hill Chapel Hill NC., Muntner P; Department of Epidemiology University of Alabama at Birmingham AL., Wang TY; Duke Clinical Research Institute Durham NC.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2020 May 05; Vol. 9 (9), pp. e014347. Date of Electronic Publication: 2020 Apr 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Cardiovascular Diseases/*prevention & control , Dyslipidemias/*drug therapy , Hypolipidemic Agents/*therapeutic use , Lipoproteins, LDL/*blood , Serine Proteinase Inhibitors/*therapeutic use, Aged ; Biomarkers/blood ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/epidemiology ; Databases, Factual ; Down-Regulation ; Drug Prescriptions ; Drug Therapy, Combination ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Female ; Humans ; Hypolipidemic Agents/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Serine Proteinase Inhibitors/adverse effects ; Time Factors ; Treatment Outcome ; United States/epidemiology

المؤلفون: Warden BA; Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States., Fazio S; Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States., Shapiro MD; Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States. Electronic address: shapirmi@ohsu.edu.

المصدر: Trends in cardiovascular medicine [Trends Cardiovasc Med] 2020 Apr; Vol. 30 (3), pp. 179-185. Date of Electronic Publication: 2019 May 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 9108337 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2615 (Electronic) Linking ISSN: 10501738 NLM ISO Abbreviation: Trends Cardiovasc Med Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Anticholesteremic Agents/*therapeutic use , Cardiovascular Diseases/*prevention & control , Dyslipidemias/*drug therapy , Lipids/*blood , Serine Proteinase Inhibitors/*therapeutic use, Anticholesteremic Agents/adverse effects ; Biomarkers/blood ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/epidemiology ; Diffusion of Innovation ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Humans ; Proprotein Convertase 9/metabolism ; Risk Factors ; Serine Proteinase Inhibitors/adverse effects ; Time Factors ; Treatment Outcome

المؤلفون: Alali RA; Department of Internal Medicine, King Fahd Hospital of the University, Alkhobar, College of Medicine, Imam Abdulrahman bin Faisal University 31441, Dammam, Saudi Arabia.

المصدر: Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2019 Mar 30; Vol. 20 (1), pp. 1-8.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: IMR Press Country of Publication: Singapore NLM ID: 100960007 Publication Model: Print Cited Medium: Internet ISSN: 1530-6550 (Print) Linking ISSN: 15306550 NLM ISO Abbreviation: Rev Cardiovasc Med Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Anticholesteremic Agents/*therapeutic use , Cardiovascular Diseases/*prevention & control , Cholesterol/*blood , Dyslipidemias/*drug therapy , Serine Proteinase Inhibitors/*therapeutic use, Animals ; Anticholesteremic Agents/adverse effects ; Biomarkers/blood ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/epidemiology ; Down-Regulation ; Dyslipidemias/blood ; Dyslipidemias/enzymology ; Dyslipidemias/epidemiology ; Humans ; Proprotein Convertase 9/metabolism ; Risk Factors ; Serine Proteinase Inhibitors/adverse effects ; Treatment Outcome

المؤلفون: Handelsman Y; Metabolic Institute of America, Tarzana, CA yhandelsman@gmail.com., Lepor NE; Cedars-Sinai Heart Institute, Beverly Hills, CA.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2018 Jun 22; Vol. 7 (13). Date of Electronic Publication: 2018 Jun 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Anticholesteremic Agents/*therapeutic use , Cardiovascular Diseases/*prevention & control , Cholesterol, LDL/*blood , Diabetes Mellitus/*drug therapy , Dyslipidemias/*drug therapy , Serine Proteinase Inhibitors/*therapeutic use, Animals ; Anticholesteremic Agents/adverse effects ; Biomarkers/blood ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/epidemiology ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/epidemiology ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Humans ; Proprotein Convertase 9/metabolism ; Risk Factors ; Serine Proteinase Inhibitors/adverse effects ; Treatment Outcome

المؤلفون: Khan SU; 1 Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA., Talluri S; 1 Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA., Riaz H; 2 Cleveland Clinic, Cleveland, OH, USA., Rahman H; 1 Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA., Nasir F; 1 Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA., Bin Riaz I; 3 Mayo Clinic, Rochester, MN, USA., Sattur S; 1 Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA., Ahmed H; 2 Cleveland Clinic, Cleveland, OH, USA., Kaluski E; 1 Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA.; 4 Rutgers New Jersey Medical School, Newark, NJ, USA.; 5 The Geisinger Commonwealth Medical College, Scranton, PA, USA., Krasuski R; 6 Duke University School of Medicine, Durham, NC, USA.

المصدر: European journal of preventive cardiology [Eur J Prev Cardiol] 2018 May; Vol. 25 (8), pp. 844-853. Date of Electronic Publication: 2018 Mar 23.

نوع المنشور: Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Anticholesteremic Agents/*therapeutic use , Cardiovascular Diseases/*prevention & control , Dyslipidemias/*drug therapy , Ezetimibe/*therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Lipids/*blood , Serine Proteinase Inhibitors/*therapeutic use, Aged ; Anticholesteremic Agents/adverse effects ; Bayes Theorem ; Biomarkers/blood ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/epidemiology ; Drug Therapy, Combination ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Ezetimibe/adverse effects ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Serine Proteinase Inhibitors/adverse effects ; Treatment Outcome

المؤلفون: Tziomalos K; First Propedeutic Department of Internal Medicine, AHEPA Hospital, 1 Stilponos Kyriakidi street, Thessaloniki, 54636, Greece.

المصدر: Current pharmaceutical design [Curr Pharm Des] 2017; Vol. 23 (10), pp. 1495-1499.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9602487 Publication Model: Print Cited Medium: Internet ISSN: 1873-4286 (Electronic) Linking ISSN: 13816128 NLM ISO Abbreviation: Curr Pharm Des Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Antibodies, Monoclonal/*pharmacology , Anticholesteremic Agents/*pharmacology , Dyslipidemias/*drug therapy , Serine Proteinase Inhibitors/*pharmacology, Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal, Humanized ; Anticholesteremic Agents/chemistry ; Cholesterol, LDL/antagonists & inhibitors ; Cholesterol, LDL/metabolism ; Dyslipidemias/metabolism ; Humans ; Proprotein Convertase 9/metabolism ; Serine Proteinase Inhibitors/chemistry

المؤلفون: Page MM; Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital , Perth , Australia., Watts GF

المصدر: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2015 Jun; Vol. 20 (2), pp. 299-312. Date of Electronic Publication: 2015 Apr 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*therapeutic use , Dyslipidemias/*drug therapy , Proprotein Convertases/*antagonists & inhibitors, Animals ; Anticholesteremic Agents/pharmacology ; Atherosclerosis/etiology ; Atherosclerosis/mortality ; Atherosclerosis/prevention & control ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/prevention & control ; Drug Design ; Dyslipidemias/complications ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Proprotein Convertase 9 ; Serine Endopeptidases

المؤلفون: Page MM; a 1 Royal Perth Hospital, Lipid Disorders Clinic, Cardiovascular Medicine , Perth, Australia., Watts GF

المصدر: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2015; Vol. 11 (9), pp. 1505-15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print Cited Medium: Internet ISSN: 1744-7607 (Electronic) Linking ISSN: 17425255 NLM ISO Abbreviation: Expert Opin Drug Metab Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Anticholesteremic Agents/*administration & dosage , Dyslipidemias/*drug therapy, Animals ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Humanized ; Anticholesteremic Agents/pharmacokinetics ; Anticholesteremic Agents/pharmacology ; Cholesterol, LDL/blood ; Drug Therapy, Combination ; Dyslipidemias/physiopathology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Proprotein Convertase 9 ; Proprotein Convertases/antagonists & inhibitors ; Serine Endopeptidases